BOSTON, Mass., June 4 Experts with in-depthproduct development and regulatory strategy experience from PAREXELInternational Corporation (Nasdaq: PRXL), a leading global biopharmaceuticalservices organization, will attend the 2008 BIO International Convention to beheld June 17-20, 2008 at the San Diego Convention Center in San Diego,California. PAREXEL has worked with the top 10 global biotechnology companies,and has helped hundreds of small and mid-size biopharmaceutical companiesdevelop and implement product and regulatory strategies as well as maximizeproduct value at every milestone and phase of development.
PAREXEL is a sponsor of the Business Forum, one of the largest partneringevents in the world, which will be held during the BIO convention. TheBusiness Forum offers opportunities for biotechnology and pharmaceuticalcompanies, academic institutions, and investors to present, meet, and discussbusiness opportunities of mutual interest.
Biopharmaceutical companies attending the BIO convention can visit Booth1337 to speak with PAREXEL experts about integrated solutions to help themreach critical clinical milestones and successfully develop products forregional and international markets. Attendees can learn about PAREXEL'sexpertise in product development, all phases of clinical research, enablingeClinical technologies, and medical communications. Additionally, companiescan find out how to leverage PAREXEL's global platform, providing a wide arrayof geographies in which to conduct clinical development programs, and accesslocal and global regulatory experience.
Hosted by the Biotechnology Industry Organization (BIO), the 2008 BIOInternational Convention will bring together more than 20,000 industry andbusiness leaders, scientists, and investors from more than 60 countries. Theconvention will address the drivers behind new medicine, processes, and otherareas of the global biotechnology industry.
For more information about PAREXEL visit www.PAREXEL.com or Booth 1337 atthe BIO convention.
About PAREXEL International
PAREXEL International Corporation is a leading global bio/pharmaceuticalservices organization, providing a broad range of knowledge-based contractresearch, medical communications and consulting services to the worldwidepharmaceutical, biotechnology and medical device industries. Committed toproviding solutions that expedite time-to-market and peak-market penetration,PAREXEL has developed significant expertise across the development andcommercialization continuum, from drug development and regulatory consultingto clinical pharmacology, clinical trials management, medical education andreimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, providesadvanced technology solutions, including medical imaging, to facilitate theclinical development process. Headquartered near Boston, Massachusetts,PAREXEL operates in 63 locations throughout 52 countries around the world, andhas more than 7,600 employees. For more information about PAREXELInternational visit www.PAREXEL.com.
This release contains "forward-looking" statements regarding futureresults and events. For this purpose, any statements contained herein that arenot statements of historical fact may be deemed forward-looking statements.Without limiting the foregoing, the words "believes," "anticipates," "plans,""expects," "intends," "appears," "estimates," "projects," "targets," andsimilar expressions are also intended to identify forward-looking statements.The forward-looking statements in this release involve a number of risks anduncertainties. The Company's actual future results may differ significantlyfrom the results discussed in the forward-looking statements contained in thisrelease. Important factors that might cause such a difference include, but arenot limited to, risks associated with: actual operating performance; actualexpense sa